Candidate biomarkers in psychiatric disorders: state of the field
Stony Brook School · Stony Brook University · +11 more institutions
Abstract
The field of psychiatry is hampered by a lack of robust, reliable and valid biomarkers that can aid in objectively diagnosing patients and providing individualized treatment recommendations. Here we review and critically evaluate the evidence for the most promising biomarkers in the psychiatric neuroscience literature for autism spectrum disorder, schizophrenia, anxiety disorders and post-traumatic stress disorder, major depression and bipolar disorder, and substance use disorders. Candidate biomarkers reviewed include various neuroimaging, genetic, molecular and peripheral assays, for the purposes of determining susceptibility or presence of illness, and predicting treatment response or safety. This review…
Citation impact
- FWCI
- 54.16
- Percentile
- 100%
- References
- 437
Authors
13- AAAnissa Abi‐DarghamCorresponding
Stony Brook School, Stony Brook University
- SJScott J. Moeller
Stony Brook School, Stony Brook University
- FAFarzana Ali
Stony Brook School, Stony Brook University
- CDChristine DeLorenzo
Stony Brook School, Stony Brook University
- KDKatharina Domschke
University of Freiburg, University Medical Center Freiburg
Topics & keywords
- Anxiety
- Neuroimaging
- Medicine
- Schizophrenia (object-oriented programming)
- Autism spectrum disorder
- Psychiatry
- Bipolar disorder
- Major depressive disorder
- Partnerships for the goals
Funding
- SFSimons Foundation
- WKWilliam K. Warren FoundationAward: 1P20GM121312
- YUYale University
- YNYale New Haven Hospital
- DFDeutsche Forschungsgemeinschaft
- NINational Institute of Mental HealthAwards: R01MH114965, R01MH114972, 1P20GM121312, R01MH123093, R01MH114296
- NINational Institute on Drug AbuseAwards: R01DA049733, R61DA056423, R01DA051420, R21DA048196, R21DA051179
- NINational Institute of General Medical SciencesAward: 1P20GM121312